NCT02251210View on ClinicalTrials.gov

Efficacy and Safety of BIIL 284 BS in Adult Patients With Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

November 30, 2002

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

BIIL 284 BS low dose

DRUG

BIIL 284 BS medium dose

DRUG

BIIL 284 BS high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY